Skip to main content
. Author manuscript; available in PMC: 2014 Dec 21.
Published in final edited form as: Inflamm Bowel Dis. 2013 Mar-Apr;19(4):754–760. doi: 10.1097/MIB.0b013e31827f27df

TABLE 1.

Demographics and Baseline Characteristics

Treatment Group
Group A (Low Dose) (n = 6) Group B (High Dose) (n = 6) Total (N = 12)
Age, yr
 Mean (SD) 42.7 (9.81) 34.0 (9.14) 38.3 (10.11)
 Median (minimum, maximum) 46.0 (24, 52) 33.5 (22, 50) 38.0 (22, 52)
Gender, n (%)
 Male 0 (0) 3 (50.0) 3 (25.0)
 Female 6 (100) 3 (50.0) 9 (75.0)
Race, n (%)
 Black or African 0 (0) 1 (16.7) 1 (8.3)
 American White 6 (100) 5 (83.3) 11 (91.7)
Ethnicity, n (%)
 Hispanic or Latino 1 (16.7) 0 (0) 1 (8.3)
 Not Hispanic or Latino 5 (83.3) 6 (100) 11 (91.7)
Baseline CDAI score
 Mean (minimum, maximum) 304.8 (234, 380) 363.5 (253, 485) 334.2 (234,485)
Baseline CRP
 Mean (SD) 8 (4.9) 49 (42.1) 28 (35.4)
Baseline IBDQ Score
 Mean (minimum, maximum) 130.0 (106, 157) 118.7 (91, 166) 124.3 (91, 166)